CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX) FOR ADVANCED GASTRIC CANCER

被引：0
|
作者：
Maeda, O. [1 ]
Ando, T. [2 ]
Ishiguro, K. [1 ]
Watanabe, O. [2 ]
Miyahara, R. [2 ]
Funasaka, K. [3 ]
Ando, Y. [4 ]
Goto, H. [2 ,3 ]
机构：
[1] Nagoya Univ, Dept Adv Res Gastroenterol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[2] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[3] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan
[4] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX) AS PERIOPERATIVE CHEMOTHERAPY FOR RESECTABLE GASTRIC AND ESOPHAGO-GASTRIC CANCER
    Marcelo, Garrido
    Maria, Sanchez
    Paula, Fonseca
    Carmen, Gonzalez-Rey
    Alberto, Carmona
    Maria, Solis
    Laura, Faez
    David, Rodriguez
    Ana, Ruiz
    Madalina, Frunza
    Juan, Briones
    Claudia, Giraldo
    Bruno, Nervi
    Alejandro, Gomez-Pinillos
    Jose Maria, Vieitez de Prado
    ANNALS OF ONCOLOGY, 2014, 25 : 39 - 39
  • [2] Modified Docetaxel plus Cisplatin plus Capecitabine (DCX) for Gastric Cancer
    Maeda, Osamu
    Ando, Yuichi
    Matsuoka, Ayumu
    Furukawa, Kazuhiro
    Funasaka, Kohei
    Miyahara, Ryoji
    Hirooka, Yoshiki
    Goto, Hidemi
    DIGESTION, 2019, 99 (01) : 113 - 113
  • [3] CHEMOTHERAPY TREATMENT PROTOCOL IN FIRST LINE ADVANCE GASTRIC CANCER WITH DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX): EFFICACY AND SAFETY DATA
    Campos, J.
    Vicent, J.
    Juarez, A.
    Llorca, C.
    Angeles, C.
    Girones, R.
    ANNALS OF ONCOLOGY, 2009, 20 : 47 - 47
  • [4] Efficacy and safety of chemotherapy DCX (DOCETAXEL-CISPLATIN-CAPECITABINE) as a perioperative treatment of gastric cancer: A single institution analysis.
    Macias Declara, Ismael
    Vila, Laia
    Luna, Alexis
    Rebasa, Pere
    Montmany, Sandra
    Malet Munte, Antoni
    Orellana, Ruth
    Marin Alcala, Maria
    Ribera Fernandez, Paula
    Martinez Vila, Clara
    Oliveres, Helena
    Navarro, Salvador
    Saigi, Eugeni
    Pericay, Carles
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Postoperative Treatment With Docetaxel, Cisplatin, and Capecitabine (DCX) and Chemoradiotherapy (CRT) With Capecitabine for Resected Gastric Adenocarcinoma
    Saridaki, Zacharenia
    Lambrodimou, Georgia
    Kachris, Stefanos
    Makrantonakis, Paris
    Boukovinas, Ioannis
    Polyzos, Aris
    Anagnostopoulos, Athanasios
    Athanasiadis, Athanasios
    Stoltidis, Dimitris
    Georgoulias, Vassilis
    Souglakos, John
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (01): : 17 - 22
  • [6] PHASE II STUDY WITH DOCETAXEL (D), CISPLATIN (C) AND CONTINUOUS CAPECITABINE (CAP) COMBINATION (DCX) IN ADVANCED GASTRIC CANCER: PRELIMINARY DATA
    Pericay, Carles
    Losa, Ferran
    Fernandez, Julen
    Alfaro, Jordi
    Pisa, Aleydis
    Salud, Antonieta
    Falco, Esther
    Vicente, Pilar
    Casado, Esther
    Saigi, Eugeni
    ANNALS OF ONCOLOGY, 2011, 22 : v48 - v48
  • [7] Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer
    Bilici, Ahmet
    Selcukbiricik, Fatih
    Demir, Nazan
    Ustaalioglu, Bala Basak Oven
    DIkillitas, Mustafa
    Yildiz, Ozcan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Modified Docetaxel and Cisplatin in Combination with Capecitabine (DCX) as a First-Line Treatment in HER2-Negative Advanced Gastric Cancer
    Bilici, Ahmet
    Selcukbiricik, Fatih
    Demir, Nazan
    Ustaalioglu, Bala Basak Oven
    Dikilitas, Mustafa
    Yildiz, Ozcan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (20) : 8661 - 8666
  • [9] A phase I/II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer.
    Kang, YK
    Kim, TW
    Chang, HM
    Ryu, MH
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 329S - 329S
  • [10] Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
    Yu, Deguo
    Wang, Zhenfeng
    He, Tingbang
    Yang, Lijun
    FRONTIERS IN SURGERY, 2022, 9
12345